Skip to main content

Advertisement

Log in

Allelic frequency of the MCP-1 promoter −2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Although genetic and environmental factors contribute to the pathogenesis of juvenile rheumathoid arthritis (JRA), the etiology and pathogenesis remain controversial. The objective of this study was to investigate genotypic and allelic frequencies of monocyte chemoattractant protein-1 (MCP-1) gene −2518 (G/A) polymorphism in the healthy Turkish population and patients with JRA. Genomic DNA was collected from 66 JRA patients and 150 healthy individuals. To evaluate the association of the −2518 (G/A) MCP-1 gene polymorphism with the outcome of JRA, we analyzed the types of JRA and the score on the childhood health assessment questionnaire (C-HAQ score). In the healthy Turkish population, the frequencies of A and G alleles were 71 and 29%, respectively. No significant difference was observed between the JRA patients and healthy subjects in the distribution allelic and genotypic frequencies of the −2518 (G/A) MCP-1 gene polymorphism (p>0.05). However, the AG genotype was found to be higher and the AA genotype was found to be lower in the patients with systemic type JRA compared to those with the other types of JRA (p=0.019). When the JRA patients were evaluated according to the C-HAQ score, we found that the −2518 (G/A) MCP-1 gene polymorphism did not relate the prognosis (p>0.05). AG genotype was found to be higher in the systemic type of JRA. The results indicate that MCP-1 gene polymorphism might slightly associate with patients with systemic JRA. Further studies are needed to elucidate the role of this polymorphism in the pathogenesis of JRA in various populations because this polymorphism has a functional significance and an ethnic difference.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cassidy JT, Petty RE (1995) Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE (eds) (1995) Textbook of pediatric rheumatology. W.B. Saunders, Philadelphia, pp 133–223

    Google Scholar 

  2. Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J et al (1977) Current proposed revision of JRA criteria subcommittee of the diagnostic and therapeutic criteria committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum 20:195–199

    PubMed  Google Scholar 

  3. Schaller JG (1997) Juvenile rheumatoid arthritis. Pediatr Rev 18:337–349

    PubMed  CAS  Google Scholar 

  4. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344–348

    Article  PubMed  CAS  Google Scholar 

  5. Jibiki T, Terai M, Shima M, Ogawa A, Hamada H, Kanazawa M et al (2001) Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 44:2211–2212

    Article  PubMed  CAS  Google Scholar 

  6. Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW et al (1986) The A study classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274–281

    Article  PubMed  CAS  Google Scholar 

  7. Dempster H, Porepa M, Young N, Feldman BM (2001) The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 44:1768–1774

    Article  PubMed  CAS  Google Scholar 

  8. Spiegel LR, Schneider R, Lang BA, Birdi N, Silverman ED, Laxer RM et al (2000) Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum 43:2402–2409

    Article  PubMed  CAS  Google Scholar 

  9. Anderson Gare B (1999) Juvenile arthritis: who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol 17:367–374

    Google Scholar 

  10. Kutukculer N, Caglayan S, Aydogdu F (1998) Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin Rheumatol 17:288–292

    Article  PubMed  CAS  Google Scholar 

  11. Ozen S, Alikasifoglu M, Bakkaloglu A, Duzova A, Jarosova K, Nemcova D et al (2002) Tumor necrosis factor alpha G A-238 and G A-308 polymorphisms in juvenile idiopathic arthritis. Rheumatology 41:223–227

    Article  PubMed  CAS  Google Scholar 

  12. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW (1995) A genetic association between juvenile rheumatoid arthritis and novel interleukin-1 alpha polymorphism. Arthritis Rheum 38:221–228

    Article  PubMed  CAS  Google Scholar 

  13. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK et al (1992) Enhanced production of monocyte chemoattractant protein-1 in the rheumatoid arthritis. J Clin Invest 90:772–779

    Article  PubMed  CAS  Google Scholar 

  14. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD et al (1994) Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 93:921–928

    PubMed  CAS  Google Scholar 

  15. Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S (1993) Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 69:83–91

    Article  PubMed  CAS  Google Scholar 

  16. Asano T, Ogawa S (2000) Expression of MCP-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy. Scand J Immunol 51:98–103

    Article  PubMed  CAS  Google Scholar 

  17. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR (1999) Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(Ipr) mice. J Exp Med 12:1813–1824

    Article  Google Scholar 

  18. Gonzalez-Escribano MF, Torres B, Aguilar F, Rodriguez R, Garcia A, Valenzuela A et al (2003) MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Hum Immunol 64:741–744

    Article  PubMed  CAS  Google Scholar 

  19. Hwang SY, Cho ML, Park B, Kim JY, Kim YH, Min DJ et al (2002) Allelic frequency of the MCP-1 promoter −2518 polymorphism in the Korean population and Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still’s disease. Eur J Immunogenet 29:413–416

    Article  PubMed  CAS  Google Scholar 

  20. Berdeli A, Ozyurek AR, Ulger Z, Gurses D, Levent E, Salar K et al (2006) Association of macrophage migration inhibitory factor gene −173 G/C polymorphism with prognosis in Turkish children with juvenile rheumathoid arthritis. Rheumatol Int 26:726–731

    Article  PubMed  CAS  Google Scholar 

  21. Lee YH, Kim HJ, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dolunay Gürses.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Özyürek, A.R., Gürses, D., Ülger, Z. et al. Allelic frequency of the MCP-1 promoter −2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis. Clin Rheumatol 26, 546–550 (2007). https://doi.org/10.1007/s10067-006-0347-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0347-6

Keywords

Navigation